Thrombocytopenia Global Clinical Trials Review, H1, 2012

GlobalData's clinical trial report, “Thrombocytopenia Global Clinical Trials Review, H1, 2012" provides data on the Thrombocytopenia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Thrombocytopenia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Thrombocytopenia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations

Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type

Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

Understand the dynamics of a particular indication in a condensed manner

Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more

Obtain discontinued trial listing for trials across the globe

Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2

List of Tables 5

List of Figures 6

Introduction 7

Thrombocytopenia 7

Report Guidance 7

Clinical Trials by Region 8

Clinical Trials by Country 9

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Top Countries Contributing to Clinical Trials in Middle East and Africa 14

Top Five Countries Contributing to Clinical Trials in Central and South America 15

Clinical Trials by BRIC Nations 16

Clinical Trials by G7 Nations 17

Clinical Trials in G7 Nations by Trial Status 18

Clinical Trials by E7 Nations 19

Clinical Trials in E7 Nations by Trial Status 20

Clinical Trials by Phase 21

In Progress Trials by Phase 22

Clinical Trials by Trial Status 23

Unaccomplished Trials of Thrombocytopenia 24

Subjects Recruited Over a Period of Time 28

Prominent Sponsors 29

Top Companies Participating in Thrombocytopenia Therapeutics Clinical Trials 31

Prominent Drug Comparison 33

Clinical Trial Profiles 34

Clinical Trial Overview of Top Companies 34

GlaxoSmithKline plc 34

Clinical Trial Overview of GlaxoSmithKline plc 34

Amgen Inc. 37

Clinical Trial Overview of Amgen Inc. 37

Eisai Inc. 39

Clinical Trial Overview of Eisai Inc. 39

Pfizer Inc. 41

Clinical Trial Overview of Pfizer Inc. 41

Octapharma AG 42

Clinical Trial Overview of Octapharma AG 42

Ono Pharmaceutical Co., Ltd. 43

Clinical Trial Overview of Ono Pharmaceutical Co., Ltd. 43

The Medicines Company 44

Clinical Trial Overview of The Medicines Company 44

AstraZeneca PLC 45

Clinical Trial Overview of AstraZeneca PLC 45

F. Hoffmann-La Roche Ltd. 46

Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 46

Grifols, S.A. 47

Clinical Trial Overview of Grifols, S.A. 47

Mylan Inc. 48

Clinical Trial Overview of Mylan Inc. 48

IMMUNOMEDICS, INC 49

Clinical Trial Overview of IMMUNOMEDICS, INC 49

CSL Limited 50

Clinical Trial Overview of CSL Limited 50

Protalex, Inc. 51

Clinical Trial Overview of Protalex, Inc. 51

Archemix Corp. 52

Clinical Trial Overview of Archemix Corp. 52

SuppreMol GmbH 53

Clinical Trial Overview of SuppreMol GmbH 53

Baxter Healthcare Corporation 54

Clinical Trial Overview of Baxter Healthcare Corporation 54

Shionogi, Inc. 55

Clinical Trial Overview of Shionogi, Inc. 55

Shire Plc 56

Clinical Trial Overview of Shire Plc 56

Talecris Biotherapeutics Holdings Corp 57

Clinical Trial Overview of Talecris Biotherapeutics Holdings Corp 57

Clinical Trial Overview of Top Universities / Institutes / Hospitals 58

Weill Cornell Medical College 58

Clinical Trial Overview of Weill Cornell Medical College 58

The University of Texas M. D. Anderson Cancer Center 59

Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 59

Assistance Publique – Hopitaux de Paris 60

Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 60

Shandong University 61

Clinical Trial Overview of Shandong University 61

University of California, San Francisco 62

Clinical Trial Overview of University of California, San Francisco 62

Christiana Care Health System 63

Clinical Trial Overview of Christiana Care Health System 63

Henri Mondor University Hospital 64

Clinical Trial Overview of Henri Mondor University Hospital 64

The Children's Hospital of Philadelphia 65

Clinical Trial Overview of The Children's Hospital of Philadelphia 65

OHSU Knight Cancer Institute 66

Clinical Trial Overview of OHSU Knight Cancer Institute 66

Brigham and Women's Hospital 67

Clinical Trial Overview of Brigham and Women's Hospital 67

Cancer Treatment Centers of America 68

Clinical Trial Overview of Cancer Treatment Centers of America 68

The Children's Hospital Los Angeles 69

Clinical Trial Overview of The Children's Hospital Los Angeles 69

Dutch haemato-oncology association 70

Clinical Trial Overview of Dutch haemato-oncology association 70

University of Alabama at Birmingham 71

Clinical Trial Overview of University of Alabama at Birmingham 71

The Hospital for Sick Children 72

Clinical Trial Overview of The Hospital for Sick Children 72

Robert H. Lurie Comprehensive Cancer Center of Northwestern University 73

Clinical Trial Overview of Robert H. Lurie Comprehensive Cancer Center of Northwestern University 73

Medical University of Vienna 74

Clinical Trial Overview of Medical University of Vienna 74

The Ohio State University 75

Clinical Trial Overview of The Ohio State University 75

Heinrich-Heine University 76

Clinical Trial Overview of Heinrich-Heine University 76

Leiden University Medical Center 77

Clinical Trial Overview of Leiden University Medical Center 77

Five Key Clinical Profiles 78

Appendix 122

Abbreviations 122

Definitions 122

Research Methodology 124

Secondary Research 124

About GlobalData 125

Contact Us 125

Disclaimer 125

Source 126

List of Tables

Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Zone, 2012* 8

Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9

Thrombocytopenia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10

Thrombocytopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012* 11

Thrombocytopenia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012* 12

Thrombocytopenia Therapeutics Clinical Trials, North America, Top Countries, 2012* 13

Thrombocytopenia Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2012* 14

Thrombocytopenia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2012* 15

Thrombocytopenia Therapeutics Clinical Trials, BRIC Countries, 2012* 16

Thrombocytopenia Therapeutics Clinical Trials, G7 Countries, 2012* 17

Thrombocytopenia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18

Thrombocytopenia Therapeutics Clinical Trials, E7 Countries, 2012* 19

Thrombocytopenia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20

Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Phase, 2012* 21

Thrombocytopenia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012* 22

Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23

Thrombocytopenia Therapeutics Market, Global, Suspended Clinical Trials, 2012* 24

Thrombocytopenia Therapeutics Market, Global, Withdrawn Clinical Trials, 2012* 25

Thrombocytopenia Therapeutics Market, Global, Terminated Clinical Trials, 2012* 26

Thrombocytopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28

Thrombocytopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 30

Thrombocytopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 32

Thrombocytopenia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2012* 34

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2012* 37

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Eisai Inc., 2012* 39

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012* 41

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Octapharma AG, 2012* 42

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ono Pharmaceutical Co., Ltd., 2012* 43

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Medicines Company, 2012* 44

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2012* 45

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2012* 46

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Grifols, S.A., 2012* 47

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Inc., 2012* 48

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by IMMUNOMEDICS, INC, 2012* 49

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by CSL Limited, 2012* 50

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Protalex, Inc., 2012* 51

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Archemix Corp., 2012* 52

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by SuppreMol GmbH, 2012* 53

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter Healthcare Corporation, 2012* 54

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shionogi, Inc., 2012* 55

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2012* 56

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Talecris Biotherapeutics Holdings Corp, 2012* 57

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Weill Cornell Medical College, 2012* 58

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Texas M. D. Anderson Cancer Center, 2012* 59

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique – Hopitaux de Paris, 2012* 60

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Shandong University, 2012* 61

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012* 62

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Christiana Care Health System, 2012* 63

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Henri Mondor University Hospital, 2012* 64

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital of Philadelphia, 2012* 65

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by OHSU Knight Cancer Institute, 2012* 66

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Brigham and Women's Hospital, 2012* 67

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cancer Treatment Centers of America, 2012* 68

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Children's Hospital Los Angeles, 2012* 69

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Dutch haemato-oncology association, 2012* 70

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Alabama at Birmingham, 2012* 71

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Hospital for Sick Children, 2012* 72

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Robert H. Lurie Comprehensive Cancer Center of Northwestern University, 2012* 73

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medical University of Vienna, 2012* 74

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2012* 75

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Heinrich-Heine University, 2012* 76

Thrombocytopenia Therapeutics Clinical Trials Market, Global, Clinical Trials by Leiden University Medical Center, 2012* 77

List of Figures

Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Zone (%), 2012* 8

Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012* 9

Thrombocytopenia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012* 10

Thrombocytopenia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012* 11

Thrombocytopenia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012* 12

Thrombocytopenia Therapeutics Clinical Trials, North America, Top Countries (%), 2012* 13

Thrombocytopenia Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2012* 14

Thrombocytopenia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2012* 15

Thrombocytopenia Therapeutics Clinical Trials, BRIC Countries (%), 2012* 16

Thrombocytopenia Therapeutics Clinical Trials, G7 Countries (%), 2012* 17

Thrombocytopenia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012* 18

Thrombocytopenia Therapeutics Clinical Trials, E7 Countries (%), 2012* 19

Thrombocytopenia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012* 20

Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Phase (%), 2012* 21

Thrombocytopenia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012* 22

Thrombocytopenia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012* 23

Thrombocytopenia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010 28

Thrombocytopenia Therapeutics Clinical Trials, Global, Key Sponsors, 2012* 29

Thrombocytopenia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012* 31

Thrombocytopenia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012* 33

GlobalData Methodology 124

    Pricing

Discounts available for multiple report purchases.

reportstore@globaldata.com
+44 (0) 161 359 5813

Join our mailing list

Saved reports